image
DEUTSCHLAND BIOTECHNOLOGIE BIONTECH
epa08809506 (FILE) - A view of the signage of German biopharmaceutical company BionTech, which is developing a vaccine against the coronavirus, in Mainz, Germany, 18 March 2020 (reissued 09 November 2020). According to a statement by Mainz-based pharmaceutical company Biontech, its vaccination allegedly offers more than 90 percent protection against the disease Covid-19. EPA/RONALD WITTEK *** Local Caption *** 56039004
Instructions
License
Rights Managed
Date created
20200318
Place
MAINZ DEUTSCHLAND
Credit
KEYSTONE
Source
EPA
Byline
RONALD WITTEK
Size
5564 x 2663 px
File type
JPEG